OLDAKOWSKI JOSEPH FRANK sold $59K of CLOV
OLDAKOWSKI JOSEPH FRANK (VP OF FINANCE AND CONTROLLER) sold 12,102 shares of CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) at $4.86 on 2026-06-16 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The newest disclosed fact is the specific open-market sale size, price, and post-transaction holdings, but the presence of a pre-arranged 10b5-1 plan limits interpretive value.
Market read
Traders may note the insider sale for sentiment monitoring, but it is unlikely to drive a fundamental repricing given the 10b5-1 structure.
What to watch
Insider sales can be offset by other insider buys or broader institutional flows; this article provides only one officer’s sale and no context on net insider activity.
Background
The article is an SEC Form 4 insider transaction disclosure for Clover Health Investments, Corp. /DE (CLOV).
Ticker impact
Clover Health insider Form 4 shows VP of Finance and Controller Joseph Frank Oldakowski sold 12,102 shares at $4.86 on 2026-06-16 under a 10b5-1 plan.
Low likelihood of sustained price impact; any reaction is likely muted and short-lived.
The filing is an SEC Form 4 insider transaction and explicitly states a pre-arranged 10b5-1 plan, which typically reduces interpretive value versus discretionary selling.
Market effects
Minimal; this is company-specific insider activity with no sector-wide regulatory/operational change.
None indicated.
None indicated.
Counterpoint
Because the sale is under a 10b5-1 plan, it may reflect scheduled liquidity rather than bearish expectations, so traders may ignore it.
Key entities
- equity issuerCLOV
Subject of the Form 4 insider transaction disclosure.
- insiderOLDAKOWSKI JOSEPH FRANK
VP of Finance and Controller who sold 12,102 shares at $4.86 on 2026-06-16 under a 10b5-1 plan.
